WATCH LIVE: FDA advisory panel considers use of peptides

Chronological Source Flow
Back

AI Fusion Summary

An FDA advisory panel began meeting on Thursday to review more than a half-dozen peptides. These substances have become an increasing wellness trend, despite the fact that there is little evidence to prove they are safe or effective. The review process is taking place at the Food and Drug Administration’s White Oak campus in Silver Spring, Maryland, as health advisers examine the specific properties and risks associated with these seven unproven peptide treatments.
Community Comments
Loading updates...
0